Stock Research for LXRX

LXRX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

LXRX Stock Chart & Research Data

The LXRX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the LXRX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


LXRX Due diligence Resources & Stock Charts

The LXRX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View LXRX Detailed Price Forecast - CNN Money CNN View LXRX Detailed Summary - Google Finance
Yahoo View LXRX Detailed Summary - Yahoo! Finance Zacks View LXRX Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View LXRX Trends & Analysis - Trade-Ideas Barrons View LXRX Major Holders - Barrons
NASDAQ View LXRX Call Transcripts - NASDAQ Seeking View LXRX Breaking News & Analysis - Seeking Alpha
Spotlight View LXRX Annual Report - CompanySpotlight.com OTC Report View LXRX OTC Short Report - OTCShortReport.com
TradeKing View LXRX Fundamentals - TradeKing Charts View LXRX SEC Filings - Bar Chart
WSJ View Historical Prices for LXRX - The WSJ Morningstar View Performance/Total Return for LXRX - Morningstar
MarketWatch View the Analyst Estimates for LXRX - MarketWatch CNBC View the Earnings History for LXRX - CNBC
StockMarketWatch View the LXRX Earnings - StockMarketWatch MacroAxis View LXRX Buy or Sell Recommendations - MacroAxis
Bullish View the LXRX Bullish Patterns - American Bulls Short Pains View LXRX Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View LXRX Stock Mentions - StockTwits PennyStocks View LXRX Stock Mentions - PennyStockTweets
Twitter View LXRX Stock Mentions - Twitter Invest Hub View LXRX Investment Forum News - Investor Hub
Yahoo View LXRX Stock Mentions - Yahoo! Message Board Seeking Alpha View LXRX Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for LXRX - SECform4.com Insider Cow View Insider Transactions for LXRX - Insider Cow
CNBC View LXRX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for LXRX - OTC Markets
Yahoo View Insider Transactions for LXRX - Yahoo! Finance NASDAQ View Institutional Holdings for LXRX - NASDAQ


Stock Charts

FinViz View LXRX Stock Insight & Charts - FinViz.com StockCharts View LXRX Investment Charts - StockCharts.com
BarChart View LXRX Stock Overview & Charts - BarChart Trading View View LXRX User Generated Charts - Trading View


Latest Financial News for LXRX

3 Top Biotech Stocks to Buy Right Now
Posted on Saturday April 21, 2018

There's good reason to consider buying shares in these biotech companies soon.


Lexicon Pharmaceuticals to Highlight Pipeline Progress at R&d Day on April 10, 2018
Posted on Tuesday April 03, 2018

THE WOODLANDS, Texas, April 03, 2018-- Lexicon Pharmaceuticals, Inc., announced today that it will host its 2018 Research & Development Day on Tuesday, April 10, 2018, from 8:30 a.m. to 11:30 a.m. EDT ...


Woodlands pharma co. total revenue 'won’t grow a lot' year over year
Posted on Monday April 02, 2018

"We have a big year ahead of us."


Lexicon Pharmaceuticals Announces EMA Acceptance of Marketing Authorization Application (MAA) for Sotagliflozin to Treat Adults With Type 1 Diabetes
Posted on Wednesday March 28, 2018

THE WOODLANDS, Texas, March 29, 2018-- Lexicon Pharmaceuticals, Inc., today announced that the European Medicines Agency has accepted the Marketing Authorization Application filed by Lexicon’ s collaborator, ...


Enter a stock symbol to view the stock details.